Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

28 ArticlesUSFDA

3 / 3

Exclusive: Sun Pharmaceutical Industries recalls 16,085 bottles of antidepressant tablets

Drug major Sun Pharmaceutical Industries Inc. (the US subsidiary of Sun Pharma), initiated a recall of antidepressant medication used to treat major depressive ...
47335-737-88_buPropionHCI_ER_USPSR_150mg_100ct.jpg

Lupin recalls 85,987 bottles of Lisinopril & Hydrochlorothiazide Tablets, second recall post EIR from USFDA

Drug major Lupin Pharmaceuticals Inc. (the US subsidiary of Lupin Pharmaceuticals), initiated a recall of Lisinopril & Hydrochlorothiazide Tables. ...
Lupin-Logo-2.png

Dr. Reddy's Laboratories recalls 84,240 bottles of Acid Controller tablets

Drug major Dr. Reddy’s Laboratories Inc. (the US subsidiary of Dr. Reddy’s), initiated a recall of Acid Controller tablets. The tablets relieves ...
DRL-Logo.png

US FDA completes the inspection of FDC's Waluj and Baddi facilties

FDC or Fairdeal Corporation as it was called back in 1986 prior to its listing in 1996 is a fully integrated pharmaceutical company. FDC manufactures and ...
FDC-Logo.png

Unichem Laboratories receives ANDA approval for Donepezil Hydrochloride Tablets

Unichem Laboratories is a specialty pharmaceutical company with a large basket of branded generics in India and several other markets across the world. ...
Unichem-Labs2.png

Lupin recalls 54,472 vials of Ceftriaxone, first recall post receipt of EIR from USFDA

Drug major Lupin Pharmaceuticals Inc. (the US subsidiary of Lupin Pharmaceuticals), initiated a recall of Ceftriaxone Sodium (Sterile) vials and the API ...
Lupin-Logo-2.png

Exclusive: Glenmark Pharmaceuticals form 483 for Pithampur facility

At Capital Mind, we bring you today another exclusive article in lines with our earlier production of the exclusive series on Lupin Pharmaceuticals form 483 ...

Premium: US FDA Warning Letter to Cadila Healthcare for Moraiya formulation facility and Ahmedabad API facility (Zyfine)

On the 23-Dec-15 (Wednesday), the US FDA issued a Warning Letter to Cadila Healthcare. The letter was in relation to the inspection performed from ...